Thomas Englese - 08 Sep 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Reporting relationship: CHIEF COMMERCIAL OFFICER
Issuer ticker: ELUT
Reported as of: 08 Sep 2022
Net transaction value: -$34,514
SEC form: 4
Accepted by SEC: 12 Sep 2022, 17:05:46 UTC
Prior SEC filing: 10 Mar 2022
Next SEC filing: 09 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese

Key filing fact

Thomas Englese filed Form 4 for AZIYO BIOLOGICS, INC. (ELUT) on 12 Sep 2022.

Key facts

This page summarizes Thomas Englese's Form 4 filing for AZIYO BIOLOGICS, INC. (ELUT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Sep 2022, 17:05.

Change

Previous filing in this sequence was filed on 10 Mar 2022.
Current net transaction value: -$34,514.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AZYO transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +15,390
Change %: +233%
Price
Shares after: 21,997
Date: 08 Sep 2022
Ownership: Direct
Footnotes: F1

AZYO transaction

Class A Common Stock

Tax liability

Transaction value: $34,514
Shares: -4,728
Change %: -21%
Price: $7.30^*
Shares after: 17,269
Date: 08 Sep 2022
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AZYO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -15,390
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 08 Sep 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 15,390
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

Footnote F2

Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

Footnote F3

The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.